Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

from NDTV News - Topstories https://ift.tt/3G5aLcc
https://ift.tt/eA8V8J